GDF15 and stage 5 chronic kidney disease: Studies have found that cytokines involved in chronic inflammation, termed “inflammaging”, or senescent-associated secretory proteins such as IL-6 and GDF-15, have been implicated with decreased survival in normal aging, disease states like end stage renal disease, and in KTx recipients (14–20).